West Pharmaceutical Services, Inc. Total Debt 2008–2025
West Pharmaceutical Services, Inc. reported $202.80M of total debt (short- plus long-term borrowings) for fiscal 2025. That was 0.1% higher than fiscal 2024. Compared with fiscal 2020, the change was -21.2%.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $202.80M | +0.1% |
| FY 2024 | $202.60M | -2.0% |
| FY 2023 | $206.80M | -1.0% |
| FY 2022 | $208.90M | -29.7% |
| FY 2021 | $297.20M | +15.4% |
| FY 2020 | $257.50M | -0.8% |
| FY 2019 | $259.60M | +32.3% |
| FY 2018 | $196.20M | -0.4% |
| FY 2017 | $197.00M | -14.7% |
| FY 2016 | $231.00M | -37.1% |
| FY 2015 | $367.50M | +1.3% |
| FY 2014 | $362.70M | -3.5% |
| FY 2013 | $375.70M | -15.4% |
| FY 2012 | $444.20M | +11.2% |
| FY 2011 | $399.50M | +11.5% |
| FY 2010 | $358.40M | -5.6% |
| FY 2009 | $379.60M | — |
| FY 2008 | $0 | — |
Source: West Pharmaceutical Services, Inc. SEC filings — balance sheet (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open WST 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
West Pharmaceutical Services, Inc. reported $202.80M of total debt (short- plus long-term borrowings) for fiscal 2025. That was 0.1% higher than fiscal 2024. Compared with fiscal 2020, the change was -21.2%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for West Pharmaceutical Services, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeWest Pharmaceutical Services, Inc. — frequently asked questions
What is West Pharmaceutical Services, Inc.'s total debt (short- plus long-term borrowings)?
West Pharmaceutical Services, Inc. (WST) reported total debt (short- plus long-term borrowings) of $202.80M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from West Pharmaceutical Services, Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.
More WST financial history
Full WST fundamentals page → · Analyze total debt (short- plus long-term borrowings) with a free tool → · All 1,500+ companies →